346 related articles for article (PubMed ID: 25711742)
1. A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner.
Fang JH; Zhou HC; Zhang C; Shang LR; Zhang L; Xu J; Zheng L; Yuan Y; Guo RP; Jia WH; Yun JP; Chen MS; Zhang Y; Zhuang SM
Hepatology; 2015 Aug; 62(2):452-65. PubMed ID: 25711742
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs miR-125b and miR-100 suppress metastasis of hepatocellular carcinoma by disrupting the formation of vessels that encapsulate tumour clusters.
Zhou HC; Fang JH; Shang LR; Zhang ZJ; Sang Y; Xu L; Yuan Y; Chen MS; Zheng L; Zhang Y; Zhuang SM
J Pathol; 2016 Dec; 240(4):450-460. PubMed ID: 27577856
[TBL] [Abstract][Full Text] [Related]
3. Dual and opposing roles of the androgen receptor in VETC-dependent and invasion-dependent metastasis of hepatocellular carcinoma.
Zhou HC; Liu CX; Pan WD; Shang LR; Zheng JL; Huang BY; Chen JY; Zheng L; Fang JH; Zhuang SM
J Hepatol; 2021 Oct; 75(4):900-911. PubMed ID: 34004215
[TBL] [Abstract][Full Text] [Related]
4. A new VETC in hepatocellular carcinoma metastasis.
Hanley KL; Feng GS
Hepatology; 2015 Aug; 62(2):343-5. PubMed ID: 25902918
[No Abstract] [Full Text] [Related]
5. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase.
Chang RM; Yang H; Fang F; Xu JF; Yang LY
Hepatology; 2014 Oct; 60(4):1251-63. PubMed ID: 24825302
[TBL] [Abstract][Full Text] [Related]
7. Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion.
Ng L; Tung-Ping Poon R; Yau S; Chow A; Lam C; Li HS; Chung-Cheung Yau T; Law WL; Pang R
Hepatology; 2013 Aug; 58(2):667-79. PubMed ID: 23504997
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-Mesenchymal Transition is Superior to Vessels-Encapsulate Tumor Cluster in Promoting Metastasis of Hepatocellular Carcinoma: a Morphological Evidence.
He C; Zhou Z; Jiang H; Yin Z; Meng S; Zhang J; Huang P; Xu K; Bian L; Xiao Z; Wang J
J Cancer; 2017; 8(1):39-47. PubMed ID: 28123596
[No Abstract] [Full Text] [Related]
9. Vessels That Encapsulate Tumor Clusters (VETC) Pattern Is a Predictor of Sorafenib Benefit in Patients with Hepatocellular Carcinoma.
Fang JH; Xu L; Shang LR; Pan CZ; Ding J; Tang YQ; Liu H; Liu CX; Zheng JL; Zhang YJ; Zhou ZG; Xu J; Zheng L; Chen MS; Zhuang SM
Hepatology; 2019 Sep; 70(3):824-839. PubMed ID: 30506570
[TBL] [Abstract][Full Text] [Related]
10. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
[TBL] [Abstract][Full Text] [Related]
11. [Angiopoietin-2 regulates vessels encapsulated by tumor clusters positive hepatocellular carcinoma nest-type metastasis via integrin α5β1].
Dong XF; Zhong JT; Liu TQ; Chen YY; Tang YT; Yang JR
Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(9):654-660. PubMed ID: 33685048
[No Abstract] [Full Text] [Related]
12. Vessels Encapsulating Tumor Clusters (VETC) Is a Powerful Predictor of Aggressive Hepatocellular Carcinoma.
Renne SL; Woo HY; Allegra S; Rudini N; Yano H; Donadon M; Viganò L; Akiba J; Lee HS; Rhee H; Park YN; Roncalli M; Di Tommaso L
Hepatology; 2020 Jan; 71(1):183-195. PubMed ID: 31206715
[TBL] [Abstract][Full Text] [Related]
13. [The relationship between vimentin protein expression in endothelial cells and contrast-enhanced ultrasound characters in VETC (+ ) hepatocellular carcinoma].
Lan CY; Ling B; Guo WW; Yin W; Zhong XG; Han YM; Dong XF
Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):105-109. PubMed ID: 29502369
[No Abstract] [Full Text] [Related]
14. Actin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transition.
Xiao S; Chang RM; Yang MY; Lei X; Liu X; Gao WB; Xiao JL; Yang LY
Hepatology; 2016 Apr; 63(4):1256-71. PubMed ID: 26698646
[TBL] [Abstract][Full Text] [Related]
15. HNRNPAB induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by transcriptionally activating SNAIL.
Zhou ZJ; Dai Z; Zhou SL; Hu ZQ; Chen Q; Zhao YM; Shi YH; Gao Q; Wu WZ; Qiu SJ; Zhou J; Fan J
Cancer Res; 2014 May; 74(10):2750-62. PubMed ID: 24638979
[TBL] [Abstract][Full Text] [Related]
16. β-Arrestin1 is involved in hepatocellular carcinoma metastasis via extracellular signal-regulated kinase-mediated epithelial-mesenchymal transition.
Xu X; Lei Y; Zhou H; Guo Y; Liu H; Jiang J; Yang Y; Wu B
J Gastroenterol Hepatol; 2020 Dec; 35(12):2229-2240. PubMed ID: 32445259
[TBL] [Abstract][Full Text] [Related]
17. Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway.
Yang S; Yang C; Yu F; Ding W; Hu Y; Cheng F; Zhang F; Guan B; Wang X; Lu L; Rao J
Cell Death Dis; 2018 Oct; 9(11):1105. PubMed ID: 30377291
[TBL] [Abstract][Full Text] [Related]
18. Higher matrix stiffness as an independent initiator triggers epithelial-mesenchymal transition and facilitates HCC metastasis.
Dong Y; Zheng Q; Wang Z; Lin X; You Y; Wu S; Wang Y; Hu C; Xie X; Chen J; Gao D; Zhao Y; Wu W; Liu Y; Ren Z; Chen R; Cui J
J Hematol Oncol; 2019 Nov; 12(1):112. PubMed ID: 31703598
[TBL] [Abstract][Full Text] [Related]
19. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
Feng XJ; Pan Q; Wang SM; Pan YC; Wang Q; Zhang HH; Zhu MH; Zhang SH
Tumour Biol; 2016 Aug; 37(8):11457-67. PubMed ID: 27010469
[TBL] [Abstract][Full Text] [Related]
20. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
